Moneycontrol
Close Ad
SENSEX NIFTY

Samrat Pharmachem Ltd.

BSE: 530125 | NSE: | ISIN: INE103E01016 | SECTOR: PHARMACEUTICALS |
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Jun 19, 16:00
131.95
4.55 (+3.57%)
VOLUME 1,239
AVERAGE VOLUME
5-Day 899
10-Day 1,396
30-Day 1,948
VOLUME SHOCKER
5-Day 899
10-Day 1,396
30-Day 1,948
Prev. Close
127.40
Open Price
129.85
Bid PRICE (QTY.)
125.20 (10)
Offer PRICE (Qty.)
131.95 (14)
VWAP 130.88
Market
Depth

Market Depth (20 Jun 2018)

BUY SELL
QTY PRICE PRICE QTY
50 127.10 131.95 14
5 127.00 132.00 200
30 126.00 132.90 23
1 125.50 133.95 500
10 125.25 134.00 150
595 Total 664 Total

Buy Qty

595

Sell QTY

664

Today's Low/High 125.50 132.90
52 Wk Low/High 49.00 170.40
L/U Price Band 101.95 152.85

Samrat Pharma is not listed on NSE

Action in Markets Today

No recommendations so far.

What's your call on Samrat Pharma today?
Read 2 investor views

Standalone
MARKET CAP (Rs Cr)
40.77
P/E
12.68
BOOK VALUE (Rs)
60.00
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
29.52
EPS (TTM)
10.41
P/C
11.23
PRICE/BOOK
2.20
DIV YIELD.(%)
-%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
96.85 new
DELIVERY AVERAGES
3-Day 94.24%
5-Day 87.39%
8-Day 85.05%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Samrat Pharma on the go with the moneycontrol app
Also available for
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

15 June 2018

buy

SunPharma Jun Fut

Entry Price (Rs)

557.30

Exit Price (Rs)

572.85

Gain (Rs)

16.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 62.40 129.85  
High Price 63.30 132.90  
Low Price 61.00 125.50  
Last Price 62.85 131.95 109.94
Volume 1,685 1,239 -26.47
Simple Moving Averages
Days BSE NSE
30 131.51
50 137.00
150 118.83
200 107.26

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Samrat Pharma

News/Videos & Announcements
Stock Advice & Research Reports
Stock Advice
No Advice
Research Reports
No Reports
News Across the Web
Financials
Income Statement
 Standalone Mar'18 Dec'17 Sep'17
Jun'17
Net Sales 26.45 25.08 20.77 20.22
Other Income 0.16 0.04 0.02 0.02
PBDIT 1.42 2.31 0.93 1.29
Net Profit 0.70 1.41 0.51 0.60

Annual Report

Download in PDF format 2017 |2016 |2015 |2014 |2013 |2012 |2011 |2010
Balance Sheet
Mar'17
(In Rs Cr)
Total Share Capital 3.09
Net Worth 15.32
Total Debt 6.59
Net Block 7.02
Investments 0.00
Total Assets 21.92
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 560.10 -1.88 608.55 433.15 134,386.16
Cipla 602.25 -0.62 663.00 508.10 48,492.64
Piramal Enter 2541.75 -0.16 3009.29 2279.05 45,902.10
Cadila Health 407.90 1.83 554.20 341.65 41,758.46
Lupin 898.30 -0.44 1176.00 723.55 40,612.42
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 18Jun' 17Mar' 17Dec' 16
Promoter48.7648.1247.8747.83
Public (FII + DII)51.2451.8852.1352.17
Others0.000.000.000.00
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
Plot No A2/3445, GIDC,,Phase IV,
City
Ankleshwar
State
Gujarat
Pin Code
393002
Tel. No.
02646-220774 02646-251291
Fax No.
02646-251291
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
City
Mumbai - 400083
State
Maharashtra
Tel. No.
022-49186270, 49186200
Fax No.
022-49186060, 49186195
MANAGEMENT
Name
Designation
Lalit Mehta
Chairman & Managing Director
Rajesh Mehta
Executive Director
Megh Mehta
Executive Director
Mahendra Pipalia
Independent Director
Samir Kothary
Independent Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

HDFC Bank Recommended on Jun 5th 2017

Recommended price 1,636.00  |  Peak from reco 2170.05 32.66%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Samrat Pharma

Samrat Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 40.77 crore.

The company management includes Lalit Mehta - Chairman & Managing Director, Rajesh Mehta - Executive Director, Megh Mehta - Executive Director, Mahendra Pipalia - Independent Director, Samir Kothary - Independent Director, Renu Dharod - Independent Director.

It is listed on the BSE with a BSE Code of 530125.

Its Registered office is at Plot No A2/3445, GIDC,,Phase IV, Ankleshwar,Gujarat - 393002.

Their Registrars are Link Intime India Pvt. Ltd.

Quick Links for Samrat Pharmachem
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Samrat Pharma